Apart from the drugs, some other therapies have proved successful to slow the onset of Alzheimer's symptoms.

The laboratory evaluates the safety and effectiveness of an investigational drug aimed at slowing the progression of Alzheimer's Disease.

The goal of the PREVENT-AD program is to study memory and brain changes in healthy people over the age of 60.

John Breitner, MD, has devoted his career to investigating factors that modify an individual’s risk of developing Alzheimer's Disease.

Watch this 2012 Mini-Psych school class "Preventing Alzheimer's Disease: an impossible dream?" by John Breitner

Judes Poirier, PhD, CQ, is the associate director of  the Centre for Studies on Prevention of Alzehimer's Disease dedicated to the prevention of AD

Improved treatments may be on the way for some 280,000 Canadians with Alzheimer’s disease.

Slowing the Onset of Alzheimer?s Symptoms : A Therapy Developed at the Douglas Provides Hope.

Stopping the progression of Alzheimer's Disease: the best hope is early diagnosis.

Major partnership paves way for new discoveries in prevention of dementia